No abstract available
Keywords:
acute lymphoblastic leukemia; blinatumomab; continuous infusion; immunotherapy; pediatrics; relapse.
MeSH terms
-
Antibodies, Bispecific / administration & dosage*
-
Antineoplastic Agents / administration & dosage*
-
Humans
-
Infusions, Intravenous / standards*
-
Infusions, Intravenous / statistics & numerical data*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
-
Prognosis
Substances
-
Antibodies, Bispecific
-
Antineoplastic Agents
-
blinatumomab